We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$93.6B
AUM Growth
+$11.5B
(+14%)
Cap. Flow
+$6.25B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
30.05%
Holding
1,605
New
33
Increased
702
Reduced
242
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$512M |
| 2 |
Apple
AAPL
|
+$497M |
| 3 |
Booking.com
BKNG
|
+$471M |
| 4 |
Microsoft
MSFT
|
+$398M |
| 5 |
AutoZone
AZO
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$351M |
| 2 |
Moody's
MCO
|
+$169M |
| 3 |
Philip Morris
PM
|
+$153M |
| 4 |
Accenture
ACN
|
+$130M |
| 5 |
Equifax
EFX
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.76% |
| 2 | Financials | 14.09% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 9.66% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Ionis Pharmaceuticals
IONS
$9.13B
| $224K | ﹤0.01% |
5,585
-489
| -8% | -$22.8K |
|
952
Novavax
NVAX
$1.31B
| $223K | ﹤0.01% |
17,645
-1,666
| -9% | -$21.5K |
|
953
Sanofi
SNY
$104B
| $223K | ﹤0.01% |
3,867
-464
| -11% | -$25.1K |
|
954
Rocket Pharmaceuticals
RCKT
$382M
| $222K | ﹤0.01% |
12,006
-1,112
| -8% | -$22.8K |
|
955
Novartis
NVS
$289B
| $217K | ﹤0.01% |
1,884
-177
| -9% | -$20.1K |
|
956
Shopify
SHOP
$196B
| $216K | ﹤0.01% |
2,694
-67
| -2% | -$4.63K |
|
957
Intellia Therapeutics
NTLA
$1.69B
| $212K | ﹤0.01% |
10,321
-966
| -9% | -$22.3K |
|
958
CVRx
CVRX
$69.3M
| $211K | ﹤0.01% |
23,937
-872
| -4% | -$7.93K |
|
959
Immatics
IMTX
$1.34B
| $208K | ﹤0.01% |
18,224
-1,720
| -9% | -$20.4K |
|
960
Arrowhead Research
ARWR
$12.6B
| $208K | ﹤0.01% |
10,725
-993
| -8% | -$24.2K |
|
961
Arcturus Therapeutics
ARCT
$215M
| $205K | ﹤0.01% |
8,814
-832
| -9% | -$17.8K |
|
962
Graham Corp
GHM
$1.32B
| $202K | ﹤0.01% |
6,833
+327
| +5% | +$9.76K |
|
963
Lufax Holding
LU
$1.34B
| $200K | ﹤0.01% |
57,328
-1,422
| -2% | -$3.72K |
|
964
Tango Therapeutics
TNGX
$4.39B
| $200K | ﹤0.01% |
25,934
-2,446
| -9% | -$23.3K |
|
965
Maravai LifeSciences
MRVI
$848M
| $200K | ﹤0.01% |
24,028
-2,266
| -9% | -$19.6K |
|
966
Roivant Sciences
ROIV
$25.5B
| $199K | ﹤0.01% |
17,250
-1,628
| -9% | -$18.5K |
|
967
Paysafe
PSFE
$347M
| $199K | ﹤0.01% |
8,863
-220
| -2% | -$4.57K |
|
968
Alphatec Holdings
ATEC
$1.43B
| $198K | ﹤0.01% |
35,606
+673
| +2% | +$5.17K |
|
969
Box
BOX
$4.51B
| $193K | ﹤0.01% |
5,900
| – | – |
|
970
Vir Biotechnology
VIR
$1.5B
| $193K | ﹤0.01% |
25,770
-2,430
| -9% | -$21.1K |
|
971
Azenta
AZTA
$1.45B
| $187K | ﹤0.01% |
3,870
-355
| -8% | -$18.5K |
|
972
dLocal
DLO
$4.15B
| $184K | ﹤0.01% |
22,966
-570
| -2% | -$4.62K |
|
|
NVEI
973
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $183K | ﹤0.01% |
5,484
-136
| -2% | -$4.49K |
|
974
Paymentus
PAY
$5.11B
| $182K | ﹤0.01% |
9,068
-225
| -2% | -$4.72K |
|
975
Regenxbio
RGNX
$705M
| $180K | ﹤0.01% |
17,163
-1,619
| -9% | -$19.7K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q3 2024 Portfolio in Review
As of Q3 2024, Mitsubishi UFJ Asset Management held 1,605 positions worth $93.6B, up 14% from $82B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Mitsubishi UFJ Asset Management deployed $6.25B of net new capital in Q3 2024, opening 33 new positions and adding to 702 existing holdings. Its largest new stake was Smurfit Westrock: 731,342 shares worth $36.1M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $351M trimmed.
- Mitsubishi UFJ Asset Management's largest Q3 2024 buy was Smurfit Westrock: 731,342 shares worth $36.1M.
- Mitsubishi UFJ Asset Management added most to CME Group in Q3 2024, an estimated $512M increase.
- Mitsubishi UFJ Asset Management's biggest Q3 2024 reduction was Danaher, cutting an estimated $351M.
- Mitsubishi UFJ Asset Management fully exited WestRock Company in Q3 2024, selling an estimated $16.7M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 30% of its $93.6B portfolio in Q3 2024.
- Mitsubishi UFJ Asset Management opened 33 new positions and closed 12 in Q3 2024.
- Mitsubishi UFJ Asset Management's portfolio value rose 14% quarter-over-quarter to $93.6B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2024, filed 8 Nov 2024.